Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

APO-ALPRAZ TABLET 0.25 mg

Approval Number

SIN07872P

Drug Name

APO-ALPRAZ TABLET 0.25 mg

Product Name

APO-ALPRAZ TABLET 0.25 mg

Approval Date

October 6, 1994

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

N05BA12

ATC Item Name

alprazolam

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Apotex Inc.

Active Ingredients

Ingredient Name

ALPRAZOLAM

Strength

0.25 mg

Drug MonographAlprazolam

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

APO-ALPRAZ TABLET 0.25 mg - HSA Approval | MedPath